{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:10:30Z","timestamp":1787890230041,"version":"build-2784847793"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T00:00:00Z","timestamp":1773532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Kratom use has increased in the USA, with its primary alkaloid, mitragynine, detected in postmortem toxicology, and implicated in reported fatalities. This study evaluated toxicologic concentrations and autopsy findings associated with deaths attributed to mitragynine. Autopsy and postmortem toxicology reports were obtained from the majority of Florida medical examiner districts over 5 years for decedents in whom mitragynine was listed as a cause of death (mitragynine-induced fatalities). A comparison group included cases from a single county in which mitragynine was detected but not deemed causal (mitragynine-associated deaths). Demographic, toxicologic, and autopsy data were abstracted using standardized instruments. Thirty-eight mitragynine-induced fatalities and 111 mitragynine-associated deaths were identified, with similar demographic characteristics between groups. Mitragynine-associated deaths all featured co-exposures, including fentanyl (n\u2009=\u200984), cocaine (n\u2009=\u200949), and ethanol (n\u2009=\u200929). Mitragynine-induced fatalities had no toxic levels of any other substance and demonstrated higher rates of pulmonary edema (55.6% vs 31.5%), hepatomegaly (47.4% vs 14.4%), minor facial trauma (18.4% vs 5.4%), and cardiomegaly (47.4% vs 11.8%). Mean blood mitragynine concentrations were substantially higher in mitragynine-induced fatalities (2486\u2009\u00b5g\/L; 95% CI 1607\u20132863) compared with mitragynine-associated deaths (179\u2009\u00b5g\/L; 95% CI 217\u2013375), suggesting a concentration-dependent association with fatal toxicity. Mitragynine toxicity accounts for a notable number of deaths.<\/jats:p>","DOI":"10.1093\/jat\/bkag017","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T12:41:32Z","timestamp":1773146492000},"source":"Crossref","is-referenced-by-count":2,"title":["Case\u2013control study of mitragynine deaths in Florida"],"prefix":"10.1093","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-1583-7083","authenticated-orcid":false,"given":"Christian M","family":"Iuteri","sequence":"first","affiliation":[{"name":"Department of Emergency Medicine, Orlando Regional Medical Center , Orlando, FL 32806,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan J","family":"Sawyers","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Orlando Regional Medical Center , Orlando, FL 32806,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connor M","family":"Byrne","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Orlando Regional Medical Center , Orlando, FL 32806,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Trojano","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Orlando Regional Medical Center , Orlando, FL 32806,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Thundiyil","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Orlando Regional Medical Center , Orlando, FL 32806,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,3,15]]},"reference":[{"key":"2026052622215690500_bkag017-B1","volume-title":"FDA and Kratom","author":"U.S. Food and Drug Administration","year":"2024"},{"key":"2026052622215690500_bkag017-B2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/00952990.2024.2414319","article-title":"At least four groups of kratom consumers in the United States: latent-class analysis of motivations for kratom use","volume":"51","author":"Hill","year":"2025","journal-title":"Am J Drug Alcohol Abuse"},{"key":"2026052622215690500_bkag017-B3","volume-title":"2023 National Survey on Drug Use and Health (NSDUH) Releases","author":"Substance Abuse and Mental Health Services Administration","year":"2025"},{"key":"2026052622215690500_bkag017-B4","doi-asserted-by":"publisher","first-page":"748","DOI":"10.15585\/mmwr.mm6529a4","article-title":"Notes from the field: kratom (Mitragyna speciosa) exposures reported to poison centers\u2013United States, 2010\u20132015","volume":"65","author":"Anwar","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026052622215690500_bkag017-B5","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1080\/15563650.2019.1569236","article-title":"Kratom exposures reported to United States poison control centers: 2011\u20132017","volume":"57","author":"Post","year":"2019","journal-title":"Clin Toxicol (Phila)"},{"key":"2026052622215690500_bkag017-B6","first-page":"187","article-title":"Description of kratom exposure events in Wisconsin as reported to the Wisconsin Poison Center, January 1, 2010 to September 1, 2022","volume":"122","author":"DeJonge","year":"2023","journal-title":"WMJ"},{"key":"2026052622215690500_bkag017-B7","doi-asserted-by":"publisher","first-page":"111329","DOI":"10.1016\/j.drugalcdep.2024.111329","article-title":"Kratom addiction per DSM-5 substance use disorder criteria and kratom physical dependence: insights from dosing amount versus frequency","volume":"260","author":"Rogers","year":"2024","journal-title":"Drug Alcohol Depend"},{"key":"2026052622215690500_bkag017-B8","doi-asserted-by":"publisher","first-page":"e20181839","DOI":"10.1542\/peds.2018-1839","article-title":"Neonatal abstinence syndrome due to maternal kratom use","volume":"142","author":"Eldridge","year":"2018","journal-title":"Pediatrics"},{"key":"2026052622215690500_bkag017-B9","first-page":"7","article-title":"The DEA changes its mind on kratom","volume":"41","author":"Gianutsos","year":"2017","journal-title":"US Pharm"},{"key":"2026052622215690500_bkag017-B10","volume-title":"Kratom (Mitragyna Speciosa)","author":"U.S. Drug Enforcement Administration, Diversion Control Division","year":"2020"},{"key":"2026052622215690500_bkag017-B11","volume-title":"The Use of the WHO\u2013UMC System for Standardised Case Causality Assessment","author":"World Health Organization","year":"2022"},{"key":"2026052622215690500_bkag017-B12","doi-asserted-by":"publisher","first-page":"e28096","DOI":"10.1371\/journal.pone.0028096","article-title":"Development and inter-rater reliability of the Liverpool adverse drug reaction causality assessment tool","volume":"6","author":"Gallagher","year":"2011","journal-title":"PLoS One"},{"key":"2026052622215690500_bkag017-B13","volume-title":"Disposition of Toxic Drugs and Chemicals in Man","author":"Baselt","year":"2020","edition":"12th"},{"key":"2026052622215690500_bkag017-B14","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1002\/cpt.2891","article-title":"Clinical assessment of the drug interaction potential of the psychotropic natural product kratom","volume":"113","author":"Tanna","year":"2023","journal-title":"Clin Pharmacol Ther"},{"key":"2026052622215690500_bkag017-B15","doi-asserted-by":"publisher","first-page":"108057","DOI":"10.1016\/j.yebeh.2021.108057","article-title":"Seizures among young adults consuming kratom beverages in Malaysia: a case series","volume":"121","author":"Halim","year":"2021","journal-title":"Epilepsy Behav"},{"key":"2026052622215690500_bkag017-B16","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s13181-010-0079-5","article-title":"Seizure and coma following kratom (Mitragyna speciosa Korth) exposure","volume":"6","author":"Nelsen","year":"2010","journal-title":"J Med Toxicol"},{"key":"2026052622215690500_bkag017-B17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ebcr.2018.04.002","article-title":"Recurrent seizures from chronic kratom use, an atypical herbal opioid","volume":"10","author":"Tatum","year":"2018","journal-title":"Epilepsy Behav Case Rep"},{"key":"2026052622215690500_bkag017-B18","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1080\/10550887.2023.2282033","article-title":"Cardiovascular health in kratom users: a narrative review","volume":"42","author":"Chichagi","year":"2024","journal-title":"J Addict Dis"},{"key":"2026052622215690500_bkag017-B19","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1080\/15563650.2020.1812627","article-title":"Is kratom (Mitragyna speciosa Korth.) use associated with ECG abnormalities? Electrocardiogram comparisons between regular kratom users and controls","volume":"59","author":"Leong Abdullah","year":"2021","journal-title":"Clin Toxicol (Phila)"},{"key":"2026052622215690500_bkag017-B20","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1016\/j.jacc.2023.04.009","article-title":"Ventricular arrhythmias associated with over-the-counter and recreational opioids","volume":"81","author":"Krantz","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2026052622215690500_bkag017-B21","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000001427","article-title":"Safety and tolerability of single and multiple daily oral doses of dried Kratom leaf powder in a randomized trial in healthy volunteers","author":"Huestis","year":"2026","journal-title":"Ther Drug Monit"},{"key":"2026052622215690500_bkag017-B22","doi-asserted-by":"publisher","first-page":"984","DOI":"10.3390\/molecules29050984","article-title":"Human Mitragynine and 7-hydroxymitragynine pharmacokinetics after single and multiple daily doses of oral encapsulated dried Kratom leaf powder","volume":"29","author":"Huestis","year":"2024","journal-title":"Molecules"},{"key":"2026052622215690500_bkag017-B23","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3389\/fpsyt.2020.00411","article-title":"Mitragynine attenuates morphine withdrawal effects in rats\u2013a comparison with methadone and buprenorphine","volume":"11","author":"Hassan","year":"2020","journal-title":"Front Psychiatry"},{"key":"2026052622215690500_bkag017-B24","doi-asserted-by":"publisher","first-page":"112462","DOI":"10.1016\/j.jep.2019.112462","article-title":"Patterns and reasons for kratom (Mitragyna speciosa) use among current and former opioid poly-drug users","volume":"249","author":"Singh","year":"2020","journal-title":"J Ethnopharmacol"},{"key":"2026052622215690500_bkag017-B25","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/s10571-020-01034-7","article-title":"Kratom alkaloids, natural and semi-synthetic, show less physical dependence and ameliorate opioid withdrawal","volume":"41","author":"Wilson","year":"2021","journal-title":"Cell Mol Neurobiol"},{"key":"2026052622215690500_bkag017-B26","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1111\/cts.13505","article-title":"An evaluation of adverse drug reactions and outcomes attributed to kratom in the U.S. Food and Drug Administration Adverse Event Reporting System from January 2004 through September 2021","volume":"16","author":"Li","year":"2023","journal-title":"Clinical Translational Sci"},{"key":"2026052622215690500_bkag017-B27","doi-asserted-by":"publisher","first-page":"1332999","DOI":"10.3389\/fpsyt.2023.1332999","article-title":"Presence of kratom in opioid overdose deaths: findings from coroner postmortem toxicological report","volume":"14","author":"Torrico","year":"2023","journal-title":"Front Psychiatry"},{"key":"2026052622215690500_bkag017-B28","doi-asserted-by":"publisher","first-page":"e110","DOI":"10.1093\/jat\/bkac016","article-title":"Two single-drug fatal intoxications by mitragynine","volume":"46","author":"Behonick","year":"2022","journal-title":"J Anal Toxicol"},{"key":"2026052622215690500_bkag017-B29","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1177\/0269881119862530","article-title":"Characteristics of deaths associated with kratom use","volume":"33","author":"Corkery","year":"2019","journal-title":"J Psychopharmacol"},{"key":"2026052622215690500_bkag017-B30","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1056\/NEJMc1811055","article-title":"Deaths in Colorado attributed to kratom","volume":"380","author":"Gershman","year":"2019","journal-title":"N Engl J Med"},{"key":"2026052622215690500_bkag017-B31","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1093\/jat\/bkz064","article-title":"The trouble with kratom: analytical and interpretative issues involving mitragynine","volume":"43","author":"Papsun","year":"2019","journal-title":"J Anal Toxicol"},{"key":"2026052622215690500_bkag017-B32","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/PAF.0000000000000691","article-title":"The causes of death and pathological findings of kratom users: a 5-year retrospective analysis","volume":"42","author":"Jittasopa","year":"2021","journal-title":"Am J Forensic Med Pathol"},{"key":"2026052622215690500_bkag017-B33","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/jat\/bkae099","article-title":"Postmortem distribution of mitragynine and 7-hydroxymitragynine in 51 cases","volume":"49","author":"Osawa","year":"2025","journal-title":"J Anal Toxicol"}],"container-title":["Journal of Analytical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jat\/advance-article-pdf\/doi\/10.1093\/jat\/bkag017\/67368519\/bkag017.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jat\/article-pdf\/50\/5\/bkag017\/67368519\/bkag017.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jat\/article-pdf\/50\/5\/bkag017\/67368519\/bkag017.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T02:22:14Z","timestamp":1779848534000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jat\/article\/doi\/10.1093\/jat\/bkag017\/8524763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,15]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,26]]}},"URL":"https:\/\/doi.org\/10.1093\/jat\/bkag017","relation":{},"ISSN":["1945-2403"],"issn-type":[{"value":"1945-2403","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,3,15]]},"article-number":"bkag017"}}